Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥36.2bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥36.8bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥5.5bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥8.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥5.7bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥8.6bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥5.7bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥8.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.0bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥6.0bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥171.7bnat 2023-09-30Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥167.3bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥30.9bnat 2023-09-30Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥140.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥140.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥55.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥70.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥74.3bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥75.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥74.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥245m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥9.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥6.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥108.182023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.292023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥158.342022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥81.452022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio82.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-09-30¥661m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-09-30¥35.6bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-09-30¥35.6bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-09-30¥7.6bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-09-30¥616m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥36.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥36.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥8.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 501
ItemContextValueUnit
Comprehensive incomePrior1YTDDuration6209000000JPY
Comprehensive incomeCurrentYTDDuration5814000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration6209000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration5814000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration8229000000JPY
Income before income taxesCurrentYTDDuration5658000000JPY
Depreciation and amortization ope cfPrior1YTDDuration1233000000JPY
Depreciation and amortization ope cfCurrentYTDDuration1291000000JPY
Impairment loss ope cfPrior1YTDDuration304000000JPY
Impairment loss ope cfCurrentYTDDuration-JPY
Amortization of goodwill ope cfPrior1YTDDuration11000000JPY
Amortization of goodwill ope cfCurrentYTDDuration117000000JPY
Increase decrease for retirement benefits asset liability ope cfPrior1YTDDuration-48000000JPY
Increase decrease for retirement benefits asset liability ope cfCurrentYTDDuration-87000000JPY
Interest and dividends income ope cfPrior1YTDDuration-236000000JPY
Interest and dividends income ope cfCurrentYTDDuration-255000000JPY
Interest expenses ope cfPrior1YTDDuration8000000JPY
Interest expenses ope cfCurrentYTDDuration8000000JPY
Loss gain on investments in partnership ope cfPrior1YTDDuration-JPY
Loss gain on investments in partnership ope cfCurrentYTDDuration2000000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-1000000JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-4000000JPY
Loss on retirement of property plant and equipment ope cfPrior1YTDDuration25000000JPY
Loss on retirement of property plant and equipment ope cfCurrentYTDDuration69000000JPY
Loss gain on sales of property plant and equipment ope cfPrior1YTDDuration-2000000JPY
Loss gain on sales of property plant and equipment ope cfCurrentYTDDuration-0JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-382000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-4870000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-1175000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-2293000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration821000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration2034000000JPY
Other net ope cfPrior1YTDDuration-455000000JPY
Other net ope cfCurrentYTDDuration-392000000JPY
Subtotal ope cfPrior1YTDDuration8332000000JPY
Subtotal ope cfCurrentYTDDuration1278000000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration236000000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration255000000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-8000000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-8000000JPY
Income taxes paid refund ope cfPrior1YTDDuration-2133000000JPY
Income taxes paid refund ope cfCurrentYTDDuration-1769000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration6427000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration-245000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-1114000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-734000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration2000000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass